정영훈 (중앙대학교 광명병원)님 | 한빛사연구자 > 한빛사

중앙대학교 광명병원

CV File

응용의학

최종업데이트 2024.06.11.

- 정영훈(중앙대학교 광명병원)
[Editorial] Genotype-Guided Antiplatelet Therapy: Promising, Yet Not Fully Tuned
- JACC-Cardiovasc. Interv., Feb 09 2026, 19 (3) S1936-8798(25)03302-3 | https://doi.org/10.1016/j.jcin.2025.12.005
- 2026-02
- 의약학
- 한빛사논문
- 정영훈(중앙대학교 광명병원)
Carriage of cytochrome 2C19 polymorphism is associated with risk of high post-treatment platelet reactivity on high maintenance-dose clopidogrel of 150 mg/day: results of the ACCEL-DOUBLE (Accelerated Platelet Inhibition by a Double Dose of Clopidogrel According to Gene Polymorphism) study
- JACC-Cardiovasc. Interv., Jul 2010, 3 (7) | https://doi.org/10.1016/j.jcin.2010.05.007
- 2010-07
- 의약학
- 상위피인용논문
- 정영훈(Sinai Center for Thrombosis Research, 현 중앙대학교 광명병원)
Usefulness of the VerifyNow P2Y12 assay to evaluate the antiplatelet effects of ticagrelor and clopidogrel therapies
- Am. Heart J., Jul 2012, 164 (1) | https://doi.org/10.1016/j.ahj.2012.03.022
- 2012-07
- 의약학
- 상위피인용논문
Diabetic Status and Thrombogenicity: Association and Prognostic Implications After Percutaneous Coronary Intervention
- JACC-Cardiovasc. Interv., Mar 24 2025, 18 (6) S1936-8798(24)01818-1 | https://doi.org/10.1016/j.jcin.2024.12.002
- 2025-03
- 의약학
- 한빛사논문
Adding cilostazol to dual antiplatelet therapy achieves greater platelet inhibition than high maintenance dose clopidogrel in patients with acute myocardial infarction
- Circ.-Cardiovasc. Interv., 2010 Feb 1;3(1):17-26 | https://doi.org/10.1161/CIRCINTERVENTIONS.109.880179
- 2010-02
- 의약학
- 상위피인용논문
Platelet-fibrin clot strength and platelet reactivity predicting cardiovascular events after percutaneous coronary interventions
- Eur. Heart J., May 28 2024, ehae296 | https://doi.org/10.1093/eurheartj/ehae296
- 2024-05
- 의약학
- 한빛사논문
Prognostic impact of hypercoagulability and impaired fibrinolysis in acute myocardial infarction
- Eur. Heart J., 2023 May 14;44(19):1718-1728 | https://doi.org/10.1093/eurheartj/ehad088
- 2023-05
- 의약학
- 한빛사논문
Clinical Impact of CYP2C19 Genotype on Clopidogrel-Based Antiplatelet Therapy After Percutaneous Coronary Intervention
- JACC-Cardiovasc. Interv., 2023 Apr 10;16(7):829-843 | https://doi.org/10.1016/j.jcin.2023.01.363
- 2023-04
- 의약학
- 한빛사논문
- 정영훈(경상대학교 의과대학, 현 중앙대학교 광명병원)
Standard- vs high-dose clopidogrel after percutaneous coronary intervention
- JAMA-J. Am. Med. Assoc., 2011 Jun 22;305(24):2520 | doi: 10.1001/jama.2011.842
- 2011-06
- 의약학
- 한빛사논문
- 정영훈(경상대학교 의과대학, 현 중앙대학교 광명병원)
We need further studies for the development of "optimized antiplatelet therapy" based on ethnicity
- J. Am. Coll. Cardiol., 2011 Jul 5;58(2):198 | https://doi.org/10.1016/j.jacc.2011.02.048
- 2011-07
- 의약학
- 한빛사논문

연구자 ID

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기